Moreover, data from UALCAN database suggested, in HCC patients with high expression of SFXN4 (n = 88), survival was poorer than in patients with low/medium expression of SFXN4 (n = 277) (Figure 3B). This evidence concerns the gene SFXN4 and hepatocellular carcinoma.